Novel immunomodulator
AssigneeVirothera Limited
InventorUrsula Gompels
Life of this patent
Estimating the term…
Abstract
The present invention relates to an immunomodulator, and in particular to a chemokine-5 like agent with activities with a range of chemokine receptors. The invention relates to the use of this chemokine-like agent and variants thereof as a medicament.
Claims30
An isolated polynucleotide comprising the nucleic acid sequence of SEQ ID NO:
- 1 or a variant thereof or nucleic acid sequences complementary thereto and variants thereof.
An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:
- 4, 5, 14, 15 or a variant thereof.
A method of identifying a patient that carries integrated iciHHV-6A, expresses the iciU83A gene or iciU83A-N transcript, the method comprising obtaining a nucleic acid sample from a patient and carrying out amplification using the primer pair defined in SEQ ID Nos 10 and 11.
A kit for identifying a patient that carries integrated iciHHV-6A, expresses the iciU83A gene or iciU83A-N transcript, the kit comprising primers for amplification of the integrated sequence, the primers comprising a sequence as defined in SEQ ID NO:
- 10 or 11.
Dependencies are inferred from the claim text.